I was of this same mindset closetinvestor. But, I

I was of this same mindset closetinvestor. But, I do think its possible that this date is out sooner than the m2m trial, given that this has a much higher liklihood of approval with success.

M2M had to be buttoned up and analyzed prior to discussing it. Particularly because we were hoping to find stat significance (which we did, despite it being a phase 2 trial)

**Side bar. Lets not forget that the primary function of phase 2 trials is to determine the proper endpoints for phase 3, so the fact that we achieved stat significance with such a small group is quite amazing.

Back to my thought. The endpoints in M2M were more complex and thus required more analysis. We will have the top line data as soon as the data set is locked.

The questions in my mind are:

1) Does the data actually get reviewed and input throughout the trial as many have suggested?
2) If so, are we just waiting on the last handful of patients (or the last block as some have suggested)?
3) Its also been suggested that the sites have 24 hours to submit the data, and 72 hours to respond to questions regarding the data. Is this week days, or are we working through the weekends to expedite this?

So many variables, that I have just decided that it can be out anytime, but I am ready to wait. I think 2 weeks on the outside.